$25.91
+0.39 (+1.53%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-5.02%
1Y
+47.05%
YTD
-4.53%
Open$25.55
Previous Close$25.52
Day High$26.25
Day Low$24.67
52W High$38.26
52W Low$15.60
Volume—
Avg Volume1.67M
Market Cap2.85B
P/E Ratio—
EPS$-0.64
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$28.48
Below
SMA 200
$22.69
Above
RSI (14)
44
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+139.6% upside
Current
$25.91
$25.91
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 155.45M | 117.88M | 476.44M |
| Net Income | -88,987,962 | -60,728,818 | -46,993,180 |
| Profit Margin | -57.2% | -54.4% | -9.9% |
| EBITDA | -402,030,186 | -289,603,182 | -41,088,618 |
| Free Cash Flow | — | — | -33,034,013 |
| Rev Growth | +31.9% | +31.9% | -6.6% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |